Afya Limited (NASDAQ:AFYA) Receives $17.60 Consensus Target Price from Analysts

Afya Limited (NASDAQ:AFYA - Get Free Report) has been assigned a consensus rating of "Strong Sell" from the five research firms that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $17.60.

AFYA has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Afya from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. UBS Group reissued a "neutral" rating and issued a $19.50 target price (up from $17.50) on shares of Afya in a research note on Thursday, June 12th. Finally, Morgan Stanley lowered Afya from an "equal weight" rating to an "underweight" rating and dropped their price target for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th.

Afya Price Performance

Shares of NASDAQ:AFYA traded down $0.50 during trading on Wednesday, reaching $17.54. The stock had a trading volume of 55,859 shares, compared to its average volume of 112,453. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.42 and a current ratio of 1.42. Afya has a 1-year low of $14.52 and a 1-year high of $19.90. The stock has a market cap of $1.64 billion, a PE ratio of 13.29, a PEG ratio of 0.61 and a beta of 0.58. The business has a fifty day moving average price of $18.45 and a 200-day moving average price of $17.31.

Institutional Trading of Afya

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio grew its position in Afya by 40.0% in the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock worth $44,000 after acquiring an additional 800 shares during the period. Tower Research Capital LLC TRC raised its holdings in Afya by 1,099.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock valued at $64,000 after buying an additional 3,695 shares during the period. JPMorgan Chase & Co. lifted its position in Afya by 2,115.9% in the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after buying an additional 6,369 shares during the last quarter. Aquatic Capital Management LLC boosted its stake in Afya by 47.6% during the fourth quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock worth $148,000 after buying an additional 3,000 shares during the period. Finally, Nuveen LLC purchased a new stake in shares of Afya in the 1st quarter valued at approximately $226,000. Institutional investors and hedge funds own 88.02% of the company's stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.